Nestlé to acquire Aimmune Therapeutics, growing food allergy portfolio 01-Sep-2020 By Rachel Arthur Swiss giant Nestlé is to acquire Aimmune Therapeutics, a biopharmaceutical company developing and commercializing treatments for food allergies. Aimmune’s Palforzia is the world’s first approved treatment for peanut allergy.